NEMIS Technologies raises CHF 7.75 million to further scale up its production and advance its internationalization strategy
scroll south
NEMIS Technologies Ltd., amongst the Top 15 Swiss Biotech Startups of 2021, announces the closing of a CHF 7.75 million Series A financing round with the participation of both institutional and private investors. NEMIS specializes in fast, easy-to-use, affordable, and reliable on-site pathogen detection solutions. The company will use the investment to scale up its production, accelerate its ongoing international expansion, boost product development and relocate to new laboratory and office facilities in Au, ZH, Switzerland. NEMIS was a Venture Leader China in 2020 and one of the TOP 100 Swiss Startups in 2021.
Arnaud Muller, NEMIS CEO, stated: “Following the great care and dedication of our team over the past year to rapidly industrialize and scale our production, the capital raised will enable us to accelerate our expansion in Europe and overseas. We also have the means to accelerate the development of additional diagnostic test kits and methods to further improve our offering, strengthen our organization in a targeted manner, and reach profitable growth. This would not be possible without the great trust from our partners and investors, for which we are very grateful.”Roger Meier, the Chairman of the Board, added: “In just three years, NEMIS has transformed itself from an interesting startup into a very dynamic and promising growth company with a value proposition that serves a rapidly growing need in an almost optimal way. We are very pleased that we were able to inspire different types of investors - from the extraordinarily successful company leader and entrepreneur to the international highly specialized, renowned Foodtech fund, who will accompany us on our further journey. With gratitude and confidence, we look forward to creating great benefit for our stakeholders.”
About health challenges from foodborne pathogens
Foodborne pathogens like Listeria Monocytogenes, Salmonella, E. Coli, and others can be found everywhere and are spreading rapidly throughout global food and supply chains. They make hundreds of thousands of consumers sick every year and can even be fatal. Contamination by microorganisms also causes huge amounts of food waste. Lastly, food manufacturers and distributors are increasingly confronted with product recalls, which cause not only immense financial costs but also major reputational damage to the companies concerned. By means of rapid detection and elimination, NEMIS is aiming at significantly reducing the health and cost burden of such pathogens to society.
NEMIS was a Venture Leader China in 2020 and one of the TOP 100 Swiss Startups in 2021.
Source: press release
